Momenteel zijn er problemen met onze Portfolio Manager tool. We werken er hard aan om die zo snel mogelijk weer online te krijgen. Dank voor uw geduld.

Analyse aandeel Nestlé

Nestlé is de grootste producent van verpakte levensmiddelen ter wereld met een omzet van ongeveer CHF 90 miljard per jaar. De breedte van zijn productportefeuille maakt de onderneming tot een belangrijke leverancier van supermarkten. (Engelstalig rapport)

Erin Lash, CFA 07 november, 2014 | 10:06
Facebook Twitter LinkedIn

INVESTMENT THESIS

As the largest packaged food and beverage firm in the world by revenue, Nestle is one of the leading players in several categories, including beverages, dairy products, confectionery, and pet care. The breadth of its product portfolio makes Nestle a core supplier to grocery stores across the world, and its distribution network is extensive. More than 20 of Nestle's brands each generate in excess of CHF 1 billion in annual sales, and the firm is particularly dominant in the bottled water category, fending off competition from beverage behemoths Coca-Cola and PepsiCo. As a result, Nestle is in a relatively strong position to negotiate with retailers for primary shelf space in stores, and we've afforded the firm a wide moat.

Even with its leading position, the firm is not content with the status quo, but continues to seek opportunities to enhance its competitive positioning. For instance, in 2012 Nestle acquired Pfizer's infant nutrition business (which generates about 85% of its sales from faster-growing emerging markets and realizes solid profitability with EBITDA margins in the mid-20s) for 5 times fiscal 2012 sales and nearly 20 times EBITDA. Despite the rich price tag, we think Nestle was all too aware of the attractiveness of this asset and sought to ensure it didn't lose out to its competitors (namely Danone and Mead Johnson). We expect Nestle will remain a consolidator in the global consumer product industry, particularly in light of its pristine balance sheet.

We're also encouraged that Nestle isn't looking to prop up growth just for the sake of it. Efforts to rationalize its product set--even after shedding 30% of its SKUs over the past two

years while at the same time bringing new products to market--are likely to continue, and should further focus resources (both personnel and financial) on the highest return opportunities (similar to actions taken by its peers). Following the announced sales of its Jenny Craig, Power Bar, Juicy Juice businesses, we wouldn't be surprised to see other underperforming businesses, like portions of the frozen food business, as next on deck to get the ax.


VALUATION

Economic Moat   Fair value   Stewardship Rating   Danone
Wide   CHF 78,00   Standard  
Moat Trend   Uncertainty   Sector  
Stable   Low  

Def. cons. goed. - verpakte goederen


BULLS

  • Nestle's brand investments are paying off in spades. For example, KitKat is now the number 1 chocolate brand in Japan, posting quite impressive global underlying sales growth of nearly 9%.

  • For investors wishing to gain broad exposure to the consumer staples industry, Nestle may be an appropriate holding.

  • We’re encouraged by management’s reference to a pullback in its own promotional spending in the frozen foods category and its focus on bringing new products to market, which we think will ultimately drive profitable sales growth longer-term.

 

 

BEARS

  • The tough economic climate is causing consumers around the globe to rein in spending, and this could cause a significant short-term reduction in consumers' impulse purchases of products such as chocolate.

  • Foreign currency movements have turned more unfavorable over the past few months (detracting 7.5% from sales in the first nine months of fiscal 2014, which is more pronounced than the 3.7% negative hit during fiscal 2013).

  • We think Nestle was forced to pay a rich premium for Pfizer's infant nutrition business or risk this valuable asset ending up in the hands of its competitors.

 

 

 

_____________________________________________________________


Overzicht aandelenanalyses >

Aanbevolen Aandelen >

20 Tips voor het beleggen in aandelen >


Meer weten over de methodologie achter Morningstar's beoordeling en waardering van ondernemingen en aandelen?
Hoe Morningstar aandelen onderzoekt en waardeert

Morningstar's sterrenrating voor aandelen

Vragen en antwoorden bij Morningstar's aandelenonderzoek


Het uitgebreide researchrapport van dit aandeel is beschikbaar voor institutionele beleggers, vermogensbeheerders en private bankers. Voor meer informatie over de ruim 1500 wereldwijde aandelen- en creditresearchrapporten kunt u contact opnemen met Morningstar via equitysales@morningstar.com.

Facebook Twitter LinkedIn

Effecten genoemd in dit artikel

Naam effectPrijsChange (%)Morningstar Rating
Nestle SA76,66 CHF-1,94Rating
Procter & Gamble Co171,08 USD0,19Rating

Over de auteur

Erin Lash, CFA  Erin Lash, CFA, is a senior stock analyst with Morningstar.

© Copyright 2024 Morningstar, Inc. Alle rechten voorbehouden.

Voorwaarden        Privacybeleid        Cookie Settings        Beleidsdocumenten